|40.80||-1.40 / -3.32%|
As of 3:59pm ET
|40.80||0.00 / 0.00%|
The 7 analysts offering 12-month price forecasts for Isis Pharmaceuticals Inc have a median target of 64.00, with a high estimate of 91.00 and a low estimate of 11.00. The median estimate represents a +56.86% increase from the last price of 40.80.
The current consensus among 9 polled investment analysts is to Hold stock in Isis Pharmaceuticals Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.